Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270
Meadows AT, Kramer S, Hopson R, et al (1983) Survival in childhood acute lymphocytic leukemia. Effect of protocol and place of treatment. Cancer Invest 1:49–55
Wagner HP, Dingeldein-Bettler I, Berchthold W, et al for the Swiss Pediatric Oncology Group (SPOG) (1995) Childhood NHL in Switzerland: incidence and survival in 120 study and 42 non-study patients. Med Pediatr Oncol 24:281–286
Lennox EL, Stiller CA, Morris-Jones PH, Wilson-Kinnier LM (1979) Nephroblastoma: treatment during 1970–3 and the effect on survival of inclusion in the first MRC trial. BMJ 2:567–569
Duffner K, Cohen ME, Flannery JT (1982) Referral patterns of childhood brain tumors in the state of Connecticut. Cancer 50:1636–1640
Nachman J, Sather HN, Buckley JD, et al (1993) Young adults 16–21 years of age at diagnosis entered onto Children’s Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment. Cancer 71:3377–3385
Boissel N, Auclerc MF, Lheritier V, et al (2003) Should adolescents (15–20y) with ALL be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2:774–780
de Bont JM, B. van der Holt B, Dekker AW, et al (2004) Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult ALL protocols in the Netherlands. Leukemia 18:2032–2053
Stock W, Sather H, Dodge RK, Bloomfield CD, Larson A, Nachman J (2000) Outcome of adolescents and young adults with ALL:A comparison of Children’s Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens (abstracts). Blood 96:467a
Albritton K, Bleyer A (2003) The management of cancer in the older adolescent. Eur J Cancer 39:2548–2599
Bleyer A, Budd T, Montello M (2005) Lack of clinical trial participation and of progress in older adolescents and young adults with cancer. Curr Probl Pediatr Adolesc Health Care 35:186–195
Bleyer A, Budd T, Montello M (2002) Cancer in older adolescents and young adults. A new frontier. POGO News 9:8–11
Bleyer WA (1996) The adolescent gap in cancer treatment. J Registry Manage 23:114–115
Bleyer WA, Tejeda H, Murphy SM, et al (1997) National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 21:366–373
Bleyer A, Montello M, Budd T, Saxman S (2003) Young adults with sarcoma: lack of clinical trial participation and lack of survival prolongation. Proc Am Soc Clin Oncol 21:816
Bleyer A, Montello M, Budd T (2004) Young adults with leukemia in the U.S. Lack of clinical trial participation and mortality reduction during the last decade. Proc Am Soc Clin Oncol 22:586
Bleyer A, Ries L, Montello M, Budd T (2003) Non-Hodgkin lymphoma: U.S. incidence, outcome and clinical trial participation from birth to age 45. First International Conference on Pediatric Non-Hodgkin Lymphoma, April 10–12, 2003, New York City
Bleyer A, Hag-Alshiekh M, Montello M, et al (2004) Older adolescents and young adults with brain tumors in the United States. Lack of clinical trial participation and of survival prolongation and mortality reduction. Proc Intl Symp Pediatr Neurooncol p 52
Bleyer A, Montello M, Budd T, Ries L (2003) CNS tumor epidemiology and outcome in the young, 2000–2009. Ten predictions for/from the United States. Neurooncology 5:29 (www.asco.org/ac/1,1003,_12-002489-00_18-002003-00_19-00104011,00.asp)
Bleyer A (2002) Older adolescents with cancer in North America. Deficits in outcome and research. Pediatr Clin North Am 49:1027–1042
Bleyer A, Albritton K (2003) Special considerations for the young adult and adolescent. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Holland JF, Frei E (eds) Holland-Frei: Cancer Medicine (6th edition). Decker, Hamilton, Ontario, Canada, pp. 2414–2422
Rauck, AM, Fremgen AM, Hutchison CL, et al (1999) Adolescent cancers in the United States: a national cancer data base (NCDB) report. J Pediatr Hematol Oncol 21:310
Birch JM (2005) Patterns of cancer incidence in teenagers and young adults: implications for aetiology. In: Eden T, Barr R, Bleyer A, Whiteson M (eds) Cancer and the Adolescent. Blackwell, Malden, Mass, pp 13–31
Bleyer A (2005) Cancer in older adolescents and young adults: reasons for lack of progress. Pediatr Blood Cancer 45:376
Mitchell AE, Scarcella DL, Rigutto GL, et al (2004) Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 180:59–62
Bleyer A (2005) Lack of participation of young people with cancer in clinical trials: impact on the U.S. In: Eden T, Barr R, Bleyer A, Whiteson M (eds) Cancer and the Adolescent. Blackwell, Malden, Mass, pp 35–42
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bleyer, A., Budd, T., Montello, M. (2007). Older Adolescents and Young Adults with Cancer, and Clinical Trials: Lack of Participation and Progress in North America. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-68152-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40842-0
Online ISBN: 978-3-540-68152-6
eBook Packages: MedicineMedicine (R0)